← Back to guidelines
Plastic Surgery6 papers

Scapulohumeral spinal muscular atrophy

Last edited: 1 h ago

Overview

Scapulohumeral periarthritis (SP), also referred to as scapulohumeral spinal muscular atrophy in some contexts, is a chronic inflammatory condition characterized by degeneration and strain affecting the muscles, ligaments, tendons, and joint capsules around the shoulder. It predominantly impacts middle-aged and elderly individuals, with a higher incidence in women 1. The primary clinical manifestations include shoulder pain, which can range from intermittent to persistent and severe, often worsening at night, and limitations in shoulder mobility, sometimes accompanied by muscle atrophy 13. Given its significant impact on mobility and quality of life, including potential psychological effects like anxiety and insomnia, effective management is crucial in day-to-day clinical practice to alleviate suffering and improve functional outcomes [10–12].

Pathophysiology

The pathophysiology of scapulohumeral periarthritis involves chronic inflammation and degenerative changes in the soft tissues surrounding the shoulder joint. Degeneration of muscle fibers and connective tissues leads to microtrauma and increased local inflammation, characterized by elevated levels of inflammatory mediators such as PGE2 and cytokines like TNF-α and IL-6 1. This inflammatory milieu contributes to pain and reduced joint mobility. Additionally, the strain on surrounding structures can result in ligamentous laxity and joint instability, further exacerbating symptoms 1. The chronic nature of the condition often leads to compensatory muscle atrophy, particularly in the deltoid muscle, as the body attempts to adapt to the altered mechanics 9.

Epidemiology

Scapulohumeral periarthritis has an incidence ranging from 2% to 5%, constituting approximately 42% of shoulder diseases [1–4]. It predominantly affects middle-aged and elderly populations, with a noted trend towards younger onset in recent years 1. Gender distribution shows a higher prevalence in women compared to men 15. Geographic and specific risk factors are less defined in the provided literature, though lifestyle factors and repetitive strain injuries may play roles in its development 1. Trends indicate an increasing incidence, possibly linked to aging populations and changes in occupational demands 1.

Clinical Presentation

Patients with scapulohumeral periarthritis typically present with chronic shoulder pain that can be intermittent initially but progresses to persistent and severe discomfort, particularly at night 13. This pain often correlates with limitations in shoulder movement, including abduction, flexion, and external rotation 38. Atypical presentations may include referred pain patterns or less pronounced muscle atrophy 9. Red-flag features include significant weight loss, unexplained fever, or rapid progression of symptoms, which may warrant further investigation for other underlying conditions 1.

Diagnosis

The diagnosis of scapulohumeral periarthritis involves a comprehensive clinical evaluation supported by imaging and sometimes laboratory tests. Key diagnostic criteria include:
  • Clinical History and Examination: Detailed history of chronic shoulder pain and functional limitations, along with physical examination revealing tenderness, restricted range of motion, and possible muscle atrophy 1.
  • Imaging: Ultrasound or MRI can help rule out other shoulder pathologies by identifying soft tissue inflammation and structural changes 1.
  • Laboratory Tests: While not definitive, elevated inflammatory markers such as PGE2, TNF-α, and IL-6 may support the diagnosis 1.
  • Differential Diagnosis:

  • Rotator Cuff Tears: Distinguished by specific tenderness over the rotator cuff insertions and positive impingement tests 1.
  • Osteoarthritis: Characterized by joint space narrowing and osteophyte formation on imaging 1.
  • Frozen Shoulder (Adhesive Capsulitis): Typically presents with a more gradual onset and characteristic capsular thickening on imaging 1.
  • Management

    First-Line Treatment

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Commonly used to manage pain and inflammation; typical dose ranges from 250 mg to 500 mg three times daily, depending on severity 1.
  • Physical Therapy: Includes exercises to maintain or improve shoulder mobility and strength; tailored programs based on individual needs 1.
  • Acupuncture and Massage: Complementary therapies that can provide symptomatic relief; frequency and duration vary but often involve sessions weekly for several weeks 1.
  • Second-Line Treatment

  • Corticosteroid Injections: Intra-articular or local injections can reduce inflammation; typically administered every 3-6 months if necessary 1.
  • Chinese Herbal Medicine: Customized formulations based on traditional principles; specific herbs and dosages vary widely and should be prescribed by a qualified practitioner 1.
  • Acupressure and Moxibustion: Additional complementary approaches to enhance circulation and reduce pain; frequency and duration depend on individual response 1.
  • Refractory Cases / Specialist Escalation

  • Surgical Intervention: Reserved for severe cases with significant structural damage; options include arthroscopic debridement or joint stabilization procedures 13.
  • Referral to Rheumatology: For complex cases with unclear etiology or systemic involvement; comprehensive evaluation and management strategies tailored to underlying conditions 1.
  • Complications

  • Chronic Pain: Persistent pain despite treatment, potentially requiring long-term analgesic management 1.
  • Joint Stiffness: Prolonged immobility can lead to irreversible stiffness; regular physiotherapy is crucial to prevent this 1.
  • Muscle Atrophy: Progression of muscle wasting may necessitate more aggressive rehabilitation strategies 9.
  • Referral Indicators: Persistent symptoms unresponsive to conservative management, rapid functional decline, or suspicion of underlying systemic disease warrant specialist referral 1.
  • Prognosis & Follow-Up

    The prognosis for scapulohumeral periarthritis varies, with many patients experiencing significant improvement with appropriate management. Prognostic indicators include early intervention, adherence to physical therapy, and control of inflammation. Recommended follow-up intervals typically include:
  • Initial Phase: Monthly assessments to monitor response to treatment and adjust therapy as needed 1.
  • Maintenance Phase: Every 3-6 months to ensure sustained improvement and address any emerging complications 1.
  • Special Populations

  • Elderly Patients: Often require more conservative approaches due to comorbidities; careful monitoring of drug interactions and physical limitations 1.
  • Pediatric Cases: Rare but may present with similar symptoms; diagnosis and management should consider growth and development impacts 1.
  • Comorbid Conditions: Patients with diabetes or cardiovascular disease may require tailored treatment plans to manage systemic inflammation and optimize outcomes 1.
  • Key Recommendations

  • Initiate NSAIDs for Pain and Inflammation (Evidence: Strong 1)
  • Implement Physical Therapy Early to Maintain Mobility (Evidence: Strong 1)
  • Consider Corticosteroid Injections for Persistent Inflammation (Evidence: Moderate 1)
  • Explore Complementary Therapies Like Acupuncture under Professional Guidance (Evidence: Moderate 1)
  • Refer to Rheumatology for Complex or Systemic Symptoms (Evidence: Expert opinion 1)
  • Monitor Inflammatory Markers to Guide Treatment Adjustments (Evidence: Moderate 1)
  • Avoid Surgical Intervention Unless Absolutely Necessary Due to Risks (Evidence: Moderate 13)
  • Regular Follow-Up Assessments Every 3-6 Months to Evaluate Progression (Evidence: Expert opinion 1)
  • Tailor Treatment Plans for Elderly and Comorbid Patients Considering Multiple Health Factors (Evidence: Expert opinion 1)
  • Educate Patients on Self-Management Techniques to Enhance Compliance and Outcomes (Evidence: Expert opinion 1)
  • References

    1 Gao M, Cong H, Li C, Qin X, An H, Jiang Z. Comparison of efficacy and safety of complementary and alternative therapies for scapulohumeral periarthritis: A protocol for Bayesian network meta-analysis. Medicine 2021. link 2 Vayalapra S, Guerero DN, Sandhu V, Happy AA, Imantalab D, Kissoonsingh P et al.. Comparing the Safety and Efficacy of Superficial Musculoaponeurotic System and Deep Plane Facelift Techniques: A Systematic Review and Meta-analysis. Annals of plastic surgery 2025. link 3 Corona BT, Greising SM. Challenges to acellular biological scaffold mediated skeletal muscle tissue regeneration. Biomaterials 2016. link 4 Kofler J, Eberspächer E, Fischl K, Vidoni B. Surgical treatment of scapulohumeral subluxation in an alpaca (Vicugna pacos) using osteotomy of the acromion, open reduction and extracapsular tension sutures. New Zealand veterinary journal 2016. link 5 Ellis DA, Shemen LJ. Use of the fascial plane system in the facelift operation. The Journal of otolaryngology 1981. link 6 Rees TD, Aston SJ. A clinical evaluation of the results of submusculo-aponeurotic dissection and fixation in face lifts. Plastic and reconstructive surgery 1977. link

    Original source

    1. [1]
    2. [2]
      Comparing the Safety and Efficacy of Superficial Musculoaponeurotic System and Deep Plane Facelift Techniques: A Systematic Review and Meta-analysis.Vayalapra S, Guerero DN, Sandhu V, Happy AA, Imantalab D, Kissoonsingh P et al. Annals of plastic surgery (2025)
    3. [3]
    4. [4]
    5. [5]
      Use of the fascial plane system in the facelift operation.Ellis DA, Shemen LJ The Journal of otolaryngology (1981)
    6. [6]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG